ACTRN12624000945527
Completed
未知
Evaluation of the efficacy of buccal midazolam in comparison with intranasal midazolam sedation in uncooperative children during dental treatment.
niversity of Damascus0 sites40 target enrollmentAugust 5, 2024
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- dental treatment
- Sponsor
- niversity of Damascus
- Enrollment
- 40
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The patient is classified as The American Society of Anesthesiologists (ASA) physical status classification system (I and II), patient’s behavior is within the second degree (negative) of the Frankle scale, and the patient needs a dental treatment which includes pulpotomy for a lower molar.
Exclusion Criteria
- •A patient who refused to participate in the study, the known hypersensitivity to midazolam, upper respiratory tract infection or tonsillar hypertrophy, children with aggressive behavior or high resistance for treatment.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Comparison of oral and buccal midazolam for pediatric dental sedatioStress in healthy uncooperative dental patient.IRCT2013020312350N1Dental school- Shahed University18
Not yet recruiting
Phase 1
To study the efficacy of Midazolam and its combination with ketamine through the nasal route before transferring children from parent company to the operation theatre, who are scheduled for surgery.CTRI/2020/05/025229Dr Aarti Agarwal
Completed
Phase 2
Evaluation the effects of oral Midazolam premedication on recall preoperative process under General Anaesthesia in children dentistryIRCT201101054224N9Vice chancellor for research, Isfahan University of Medical Sciences60
Completed
Phase 2
Comparative Evaluation of Two Sedatives in Pediatric Dental Procedure - A Randomized Clinical TrialHealth Condition 1: K040- PulpitisCTRI/2022/02/040572arsinhbhai Patel Dental College and Hospital25
Active, not recruiting
Phase 1
Efficacité et sécurité du midazolam oral pour la réalisation des soins chez les patients en refus de soin présentant des troubles neurocognitifs modérément sévères à sévèresCTIS2023-510277-33-00Centre Hospitalier Universitaire Grenoble Alpes30